22 results
8-K
EX-10.1
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Unicycive Announces $50 Million Private Placement
4:28pm
8-K
EX-10.1
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-10.1
UNCY
Unicycive Therapeutics Inc
10 Apr 23
Entry into a Material Definitive Agreement
6:16am
8-K
EX-10.1
UNCY
Unicycive Therapeutics Inc
6 Mar 23
Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug Renazorb
5:02pm
8-K
EX-10.2
UNCY
Unicycive Therapeutics Inc
6 Mar 23
Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug Renazorb
5:02pm
8-K
EX-10.1
4o8l8wdq
2 Feb 23
Unicycive Announces Exclusive License and Development Agreement with Lotus for Renazorb in the Republic of Korea
4:45pm
8-K
EX-10.1
88w02z95nazl w6k
18 Jul 22
Expands and accelerates Renazorb opportunity in important markets for patients with hyperphosphatemia through local partner with deep domain expertise
4:15pm
S-1/A
EX-10.2
56sfgfsvc6q327a8l
7 Jun 21
IPO registration (amended)
7:01am
S-1/A
EX-10.6
rwdo6yn4 cllna7vpn0
7 Jun 21
IPO registration (amended)
7:01am
S-1/A
EX-10.1
ntk 1kyjfl
7 Jun 21
IPO registration (amended)
7:01am
S-1/A
EX-10.5
j0mf t9qfx
7 Jun 21
IPO registration (amended)
7:01am
S-1/A
EX-10.4
5p16ixx2wq
7 Jun 21
IPO registration (amended)
7:01am
S-1
EX-10.7
93i4h4
21 May 21
IPO registration
4:07pm
S-1
EX-10.8
ef1b6j4z93w
21 May 21
IPO registration
4:07pm
S-1
EX-10.9
c9dn5ou8vetn33ud
21 May 21
IPO registration
4:07pm
S-1
EX-10.10
nxq 9pacnr5
21 May 21
IPO registration
4:07pm
S-1
EX-10.3
6u47iejl
21 May 21
IPO registration
4:07pm
DRS/A
EX-10.2
70p656nc loltlz1v17
29 Apr 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.6
gspcqwh74cp0iy6v3wm
29 Apr 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.4
yodr27
29 Apr 21
Draft registration statement (amended)
12:00am